Skip to content
Recall Observatory FDA recall evidence

Drug product

Prazosin Hydrochloride Capsules, USP, 2mg, 100-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ, Manufactured by: Appco Pharma LLC, Piscataway, NJ, NDC 70377-067-11.

D-0420-2026

March 27, 2026

Class II

Product summary

Firm
Appco Pharma LLC
Event
Event 98658
Status
Ongoing
Classification
Class II
Quantity
58,896 bottles- 100's count
Official record key
drug-enforcement:D-0420-2026

Official wording

Reason: cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.

Code information: Lot:2404153UC, Exp.: 2026/MAR; 2404154UC, Exp.:2026/MAR; 2502055UC, Exp.: 2027/JAN; 2505173UC, Exp.: 2027/MAY; 2505175UC, Exp.: 2027/MAY.

Distribution pattern: U.S.A. Nationwide

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity
  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    cGMP deviation